Commentary: Case report: Daratumumab treatment in pre-transplant alloimmunization and severe hemolytic anemia

Saved in:
Bibliographic Details
Published inFrontiers in immunology Vol. 14; p. 1133382
Main Authors Jacobs, Jeremy W, Booth, Garrett S, Allen, Elizabeth S, Adkins, Brian D
Format Journal Article
LanguageEnglish
Published Switzerland Frontiers Media S.A 27.01.2023
Subjects
alloimmunization
Anemia, Sickle Cell - immunology
Antibodies, Monoclonal - adverse effects
daratumumab
Erythrocytes - immunology
Humans
immunohematology
Immunology
pre-transfusion testing
red blood cell antibodies
transfusion medicine
alloantibody
transfusion medicine
alloimmunization
pre-transfusion testing
daratumumab
immunohematology
red blood cell antibodies
sickle cell disease
Online AccessGet full text

Cover

More Information
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
ObjectType-Commentary-3
content type line 23
This article was submitted to Alloimmunity and Transplantation, a section of the journal Frontiers in Immunology
Edited by: Ilias Doxiadis, University Hospital Leipzig, Germany
Reviewed by: France Pirenne, Université Paris-Est Créteil Val de Marne, France; Harold Cliff Sullivan, Emory University, United States
ISSN:1664-3224
1664-3224
DOI:10.3389/fimmu.2023.1133382